Silverarc Capital Management’s Wave Life Sciences WVE Stock Holding History

Silverarc Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,050,374	Closed	-$8.49M	–	90
2025 Q1	$8.49M	Buy	1,050,374 +441,477	+73%	+$4.83M	1.77%	18
2024 Q4	$7.53M	Sell	608,897 -18,655	-3%	-$249K	1.68%	20
2024 Q3	$5.15M	Buy	627,552 +132,081	+27%	+$790K	1.16%	31
2024 Q2	$2.47M	Hold	495,471	–	–	0.61%	49
2024 Q1	$3.06M	Buy	+495,471	New	+$2.48M	0.86%	36
2023 Q1	–	Sell	-50,000	Closed	-$350K	–	105
2022 Q4	$350K	Buy	+50,000	New	+$230K	0.12%	81
2021 Q3	–	Sell	-123,972	Closed	-$826	–	109
2021 Q2	$826	Buy	123,972 +83,972	+210%	+$549K	0.4%	68
2021 Q1	$224K	Buy	+40,000	New	+$384K	0.13%	84

Other funds holding WVE

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return